755
Views
12
CrossRef citations to date
0
Altmetric
Review

Developments on antibiotics for multidrug resistant bacterial Gram-negative infections

, &
Pages 387-401 | Received 24 Jan 2019, Accepted 18 Apr 2019, Published online: 27 May 2019

Keep up to date with the latest research on this topic with citation updates for this article.

Read on this site (2)

Kirsten R. I. S. Dorresteijn, Matthijs C. Brouwer, Korné Jellema & Diederik van de Beek. (2020) Bacterial external ventricular catheter-associated infection. Expert Review of Anti-infective Therapy 18:3, pages 219-229.
Read now

Articles from other publishers (10)

Zahra Goudarzi, Fattaneh Danayi, Khosro Keshavarz & Ahmad Gholami. (2023) Cost-effectiveness analysis of ceftazidime avibactam versus colistin in carbapenem-resistant enterobacteriaceae in Iran. Cost Effectiveness and Resource Allocation 21:1.
Crossref
Yosra A. Helmy, Khaled Taha-Abdelaziz, Hanan Abd El-Halim Hawwas, Soumya Ghosh, Samar Sami AlKafaas, Mohamed M. M. Moawad, Essa M. Saied, Issmat I. Kassem & Asmaa M. M. Mawad. (2023) Antimicrobial Resistance and Recent Alternatives to Antibiotics for the Control of Bacterial Pathogens with an Emphasis on Foodborne Pathogens. Antibiotics 12:2, pages 274.
Crossref
Silvia Corcione, Tommaso Lupia & Francesco Giuseppe De Rosa. (2021) Novel Cephalosporins in Septic Subjects and Severe Infections: Present Findings and Future Perspective. Frontiers in Medicine 8.
Crossref
Hang Thi Nguyen, Henrietta Venter, Tania Veltman, Ruth Williams, Lisa Anne O'Donovan, Cecilia C. Russell, Adam McCluskey, Stephen W. Page, Abiodun David Ogunniyi & Darren J. Trott. (2021) In vitro synergistic activity of NCL195 in combination with colistin against Gram-negative bacterial pathogens. International Journal of Antimicrobial Agents 57:5, pages 106323.
Crossref
Poulomi Chakraborty, Payel Paul, Monika Kumari, Surajit Bhattacharjee, Mukesh Singh, Debasish Maiti, Debabrata Ghosh Dastidar, Yusuf Akhter, Taraknath Kundu, Amlan Das & Prosun Tribedi. (2021) Attenuation of Pseudomonas aeruginosa biofilm by thymoquinone: an individual and combinatorial study with tetrazine-capped silver nanoparticles and tryptophan. Folia Microbiologica 66:2, pages 255-271.
Crossref
Aun Raza, Shih Chen Ngieng, Fekade Bruck Sime, Peter J. Cabot, Jason A. Roberts, Amirali Popat, Tushar Kumeria & James R. Falconer. (2021) Oral meropenem for superbugs: challenges and opportunities. Drug Discovery Today 26:2, pages 551-560.
Crossref
Carolina Secreto, Alessandro Busca, Tommaso Lupia, Silvia Corcione & Francesco Giuseppe De Rosa. (2020) The Management of Hematologic Patients with Bloodstream Infections Due to Multi-Drug Resistant Bacteria: Where Do We Stand? From Antibacterial Prophylaxis to the Treatment of Septic Shock. Hemato 1:2, pages 60-76.
Crossref
Iván Darío Ocampo-Ibáñez, Yamil Liscano, Sandra Patricia Rivera-Sánchez, José Oñate-Garzón, Ashley Dayan Lugo-Guevara, Liliana Janeth Flórez-Elvira & Maria Cristina Lesmes. (2020) A Novel Cecropin D-Derived Short Cationic Antimicrobial Peptide Exhibits Antibacterial Activity Against Wild-Type and Multidrug-Resistant Strains of Klebsiella pneumoniae and Pseudomonas aeruginosa . Evolutionary Bioinformatics 16, pages 117693432093626.
Crossref
V. Prakash Reddy. 2020. Organofluorine Chemistry. Organofluorine Chemistry 133 214 .
Burkhard Tümmler. (2019) Emerging therapies against infections with Pseudomonas aeruginosa. F1000Research 8, pages 1371.
Crossref

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.